Invesco BulletShares 202... (NASDAQ:BSML)
Historical Stock Chart
From Feb 2020 to Feb 2025
WALNUT CREEK, Calif., April 17 /PRNewswire-FirstCall/ -- BriteSmile, Inc. (NASDAQ:BSML), a leading provider of state-of-the-art teeth-whitening systems, today released results for the quarter and year ended December 31, 2005. BriteSmile (the "Company") determined to sell its business operations in 2005. The Company sold its Associated Center business in March 2006 and signed an agreement in January 2006 to sell its Center business, which it expects to close in April 2006. As a result of the Company's determination to sell its operations, the financial information included in this release is presented in two different formats. First, it is presented on a continued operations basis reflecting a full operating statement and balance sheet consistent with the presentation of prior quarters in 2005. Second, it is presented on a discontinued operations basis, reflecting all revenue and associated operating expenses condensed into gain or loss from discontinued operations, as well as assets and liabilities held for sale on the balance sheet. The discontinued operations basis is disclosed and explained fully in the Company's Form 10-K recently filed with the Securities and Exchange Commission.
The following paragraphs summarize the results for the fourth quarter and full year of 2005 on a continuing operations basis. It should be noted that there were 14 weeks and 53 weeks, respectively, in the Company's fiscal fourth quarter and full year 2005, compared to 13 weeks and 52 weeks in 2004. The additional week in 2005 resulted from the Company's accounting policy to end the fiscal year on the last Saturday of each year.
Total revenue for the fourth quarter of 2005 was $10.2 million, up 6% compared to $9.6 million in the fourth quarter of 2004. The net loss in the quarter was $(3.3) million or $(0.31) per share, compared with a loss of $(3.3) million or $(0.32) in the same quarter last year.
Earnings in the fourth quarter of 2005, before interest, tax, depreciation, and amortization (EBITDA), were $(0.7) million. This compares to an EBITDA of $(2.4) million in the fourth quarter of 2004. EBITDA is a non- GAAP financial measure. It reflects operating income excluding depreciation and amortization of approximately $1.6 million and $1.7 million in the fourth quarter of 2005 and 2004, respectively. More information regarding this non- GAAP financial measure, and a reconciliation of EBITDA to net loss, the most directly comparable GAAP measure, is provided below.
Total revenue for fiscal year 2005 was $40.0 million, down 13% compared to $46.0 million in 2004.
The net loss in fiscal year 2005 was $(17.8) million or $(1.69) per share, compared with a loss of $(7.8) million or $(0.76) per share in 2004.
EBITDA in fiscal year 2005 was $(11.1) million. This compares to an EBITDA of $(1.2) million in 2004. EBITDA in 2005 and 2004 reflects operating income excluding depreciation and amortization of approximately $6.5 million and $6.8 million, respectively.
BriteSmile will not have an earnings conference call this quarter. Please consult the Company's Form 10-K recently filed with the SEC for more information regarding 2005 results and the recent events related to the sale of BriteSmile's businesses.
This release, other than historical information, consists of forward- looking statements that involve risks and uncertainties such as the Company's ability to close the sale of its Center division. Readers are referred to the documents filed by BriteSmile with the Securities and Exchange Commission, specifically the Company's most recent reports on Forms 10-K and 10-Q, that identify important risk factors which could cause actual results to differ from those contained in the forward-looking statements. BriteSmile and its affiliates disclaim any intent or obligation to update these forward-looking statements.
Non-GAAP Financial Information
BriteSmile provides non-GAAP EBITDA or earnings before interest, taxes, depreciation and amortization as additional information for its operating results. These measures are not in accordance with, or an alternative for financial measures calculated in accordance with generally accepted accounting principles, including net income or loss, the most directly comparable GAAP measure, and may be different from non-GAAP measures used by other companies. BriteSmile's management believes this non-GAAP measure is useful to investors because of: (i) the significant amount of non-cash depreciation and amortization incurred by the Company in its operating results ($6.5 million in 2005 and $6.8 million in 2004) and (ii) a mark-to-market gain in financial instruments relating to the December 2004 convertible debt offering is a significant non-operating and non-cash impact on earnings (mark-to-market gains were $3.8 million in 2005 and $1.1 million in 2004). Investors are cautioned that the items excluded from EBITDA are significant components in understanding and assessing BriteSmile's financial performance.
BriteSmile, Inc.
Condensed Consolidated Statements of Operations Data
Continuing Operations Basis
(unaudited)
($ in thousands, except share data)
14 Weeks 13 Weeks 53 Weeks 52 Weeks
Ended Ended Ended Ended
Dec 31, Dec 25, Dec 31, Dec 25,
2005 2004 2005 2004
REVENUES:
Center whitening fees, net $4,675 $3,517 $17,434 $17,107
Associated Center whitening
fees, net 3,889 4,473 16,741 21,081
Product and other revenue 1,629 1,602 5,821 7,781
Total revenues, net 10,193 9,592 39,995 45,969
OPERATING COSTS AND EXPENSES:
Operating and occupancy
costs 4,325 4,696 18,078 17,361
Selling, general and
administrative expenses 6,570 7,259 32,719 29,360
Research and development
expenses 45 59 266 484
Total Operating Costs and
Expenses, excluding
depreciation and
amortization 10,940 12,014 51,064 47,205
Operating income (loss)
before depreciation and
amortization (EBITDA) (747) (2,422) (11,069) (1,236)
Depreciation and
amortization 1,627 1,708 6,498 6,750
Loss from operations (2,374) (4,130) (17,567) (7,986)
Gain (loss) on mark-to-
market of convertible
note instruments 18 1,060 3,811 1,060
Other income/(expense), net (938) (265) (3,864) (799)
Loss before income tax
provision (3,294) (3,335) (17,620) (7,725)
INCOME TAX 1 6 152 95
Net loss $(3,295) $(3,341) $(17,772) (7,820)
BASIC AND DILUTED NET LOSS
PER SHARE $(0.31) $(0.32) $(1.69) $(0.76)
WEIGHTED AVG SHARES - BASIC
AND DILUTED 10,549,130 10,339,294 10,534,553 10,291,714
BRITESMILE, INC.
Reconciliation of Non-GAAP financial measures - EBITDA to Net Loss
CONTINUING OPERATIONS BASIS
(unaudited)
($ in thousands)
14 Weeks 13 Weeks 53 Weeks 52 Weeks
Ended Ended Ended Ended
Dec 31, Dec 25, Dec 31, Dec 25,
2005 2004 2005 2004
Net loss $(3,295) $(3,341) $(17,772) $(7,820)
Add back: Other expense, net 938 265 3,864 799
Add back: Income tax expense 1 6 152 95
Add back: Depreciation and
amortization 1,627 1,708 6,498 6,750
Gain from mark-to-market of
financial instruments related to
convertible debt (18) (1,060) (3,811) (1,060)
EBITDA $(747) $(2,422) $(11,069) $(1,236)
BRITESMILE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
($ in thousands, except share data)
December 31, December 25,
2005 2004
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $5,518 $18,880
Trade accounts receivable 1,675 2,118
Inventories 916 1,635
Prepaid expenses and other 1,296 704
Total current assets 9,405 23,337
PROPERTY AND EQUIPMENT, net 10,250 12,426
OTHER ASSETS 3,371 3,843
INTANGIBLES, net 4,816 5,469
TOTAL ASSETS $27,842 $45,075
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $3,693 $5,182
Accrued liabilities 9,495 6,867
Deferred revenue 2,252 1,049
Current portion of long-term debt and
capital lease obligations 14,585 3,062
Total current liabilities 30,025 16,160
LONG-TERM LIABILITIES:
Long-term debt and capital lease
obligations -- 15,650
Other long term liabilities 268 683
Total long-term liabilities 268 16,333
Total liabilities 30,293 32,493
STOCKHOLDERS' EQUITY:
Common stock 38 38
Additional paid-in capital 173,340 170,601
Accumulated deficit (175,829) (158,057)
Total shareholders' equity (2,451) 12,582
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $27,842 $45,075
BRITESMILE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS DATA
DISCONTINUED OPERATIONS BASIS
(unaudited)
($ in thousands, except share data)
53 Weeks 52 Weeks
Ended Ended
Dec 31, Dec 25,
2005 2004
REVENUES:
Center whitening fees, net $-- $--
Associated Center whitening fees, net -- --
Product and other revenue -- --
Total revenues, net -- --
OPERATING COSTS AND EXPENSES:
Operating and occupancy costs -- --
Selling, general and administrative expenses 8,410 8,288
Research and development expenses 266 484
Depreciation and amortization 809 876
Total Operating Costs and Expenses 9,485 9,648
Gain (loss) on mark-to-market of convertible
note instruments 3,811 1,060
Other income/(expense), net (3,992) (884)
Loss from continuing operations before
income tax (9,665) (9,472)
INCOME TAX 152 95
Net loss from continuing operations $(9,817) (9,567)
Income (Loss) from discontinued operations,
net of tax (7,955) 1,747
NET LOSS ATTRIBUTABLE TO COMMON
SHAREHOLDERS $(17,772) $(7,820)
BASIC AND DILUTED NET LOSS PER SHARE FOR
CONTINUING OPERATIONS $(0.93) $(0.93)
BASIC AND DILUTED NET LOSS PER SHARE FOR
DISCONTINUED OPERATIONS $(0.76) $0.17 1)
BASIC AND DILUTED NET LOSS PER COMMON SHARE $(1.69) $(0.76)
WEIGHTED AVERAGE SHARES - BASIC 10,534,553 10,291,714
WEIGHTED AVERAGE SHARES - DILUTED 10,534,553 11,073,098
1) In 2004, the gain per common share for the discontinued operation was
$0.17 for basic earnings per share and $0.16 for diluted earnings per
share.
BRITESMILE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
DISCONTINUED OPERATIONS BASIS
(unaudited)
($ in thousands, except share data)
December 31, December 25,
2005 2004
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $5,504 $18,880
Assets held for sale 19,213 22,478
Prepaid expenses and other 750 638
Total current assets 25,467 41,996
PROPERTY AND EQUIPMENT, net 629 648
OTHER ASSETS 280 1,102
INVESTMENTS, RESTRICTED AS TO USE 1,466 1,329
TOTAL ASSETS $27,842 $45,075
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $3,598 $5,027
Accrued liabilities 7,527 5,315
Accrual for store closures 403 155
Liabilities held for sale 4,678 3,526
Accrued interest due to a related party 264 --
Long-term debt with related party - current
portion 6,024 100
Convertible debt - current portion 6,828 --
Convertible debt with related party - current
portion 621 --
Financial instruments related to convertible
dept - current portion 9 432
Capital lease obligation with related party
- current portion 73 1,605
Total current liabilities 30,025 16,160
LONG-TERM LIABILITIES:
Long-term debt and capital lease obligations -- 15,650
Other long term liabilities 268 683
Total long-term liabilities 268 16,333
Total liabilities 30,293 32,493
STOCKHOLDERS' EQUITY:
Common stock 38 38
Additional paid-in capital 173,340 170,601
Accumulated deficit (175,829) (158,057)
Total shareholders' equity (2,451) 12,582
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $27,842 $45,075
DATASOURCE: BriteSmile, Inc.
CONTACT: investors, Kenneth A. Czaja, CFO of BriteSmile, Inc.,
+1-925-941-6260
Web site: http://www.britesmile.com/